CCSD code 0022G: C-MYC gene test billing guide
CCSD code 0022G covers single gene C-MYC (MYC) testing, a molecular pathology test UK insurers reimburse with prior authorization.
CCSD code 0024B: BH4 pre compounding test billing guide
CCSD code 0024B is the BH4 pre compounding test, a diagnostic code listed in the Pathology chapter of the CCSD Schedule and used to bill UK private medical insurers. Because it is a diagnostic test code rather than a procedure code, it’s submitted and paired differently from the surgical codes most billing guides describe. This […]
CCSD code 0006G: KRAS mutation analysis billing guide
CCSD code 0006G is the code UK private medical insurers recognise for KRAS mutation analysis, a molecular pathology test that checks a tumour sample for mutations in the KRAS gene. Because KRAS status shapes targeted-treatment decisions in cancers such as colorectal and non-small cell lung cancer, the test is usually requested by an oncologist and […]
CCSD code 1552B: Haemoglobin F (HbF) level blood test
CCSD code 1552B is the CCSD Schedule code for a Haemoglobin F (HbF) level blood test, used to help investigate and monitor haemoglobinopathies such as beta-thalassaemia and sickle cell disease. This guide covers what the code represents clinically, which UK insurers recognise it, and how to document and submit a compliant claim through Healthcode. CCSD […]
CCSD code 0632G: Endoscopic dilatation of oesophagus billing guide
CCSD code 0632G is the code for endoscopic dilatation of the oesophagus, a procedure used to widen a section of the oesophagus (the gullet) that has narrowed, most often because of a stricture. The procedure is carried out endoscopically, meaning the specialist passes a flexible scope down the oesophagus rather than operating through an open […]
CCSD code 0416H: 6-monoacetylmorphine (6-MAM) level test billing guide
CCSD code 0416H identifies the 6-monoacetylmorphine (6-MAM) level test, a diagnostic pathology code filed under Chapter 34 (Pathology), Section 34.1 (Biochemistry), of the CCSD Diagnostic Schedule. 6-MAM is a metabolite the body produces only when it breaks down heroin (diacetylmorphine). Because no other opioid, and nothing in poppy seeds, produces it, a confirmed 6-MAM result […]
CCSD code 0153B: Kaolin clotting time (KCT) billing guide
CCSD code 0153B: Test definition and clinical scope CCSD code 0153B is the CCSD Schedule code for the kaolin clotting time (KCT), a coagulation screening blood test. It’s one of the tests used to help detect a lupus anticoagulant, an antiphospholipid antibody linked to unexplained blood clots and recurrent miscarriage. It sits within Chapter 34 […]
CCSD Code 0593B: Plasma Guanidinoacetate (GUAP) Blood billing guide
CCSD Code 0593B: Definition and clinical context CCSD Code 0593B covers the Plasma Guanidinoacetate (GUAP) Blood test, a specialist metabolic assay used to investigate suspected creatine deficiency syndromes and inborn errors of metabolism. The code was added to the CCSD Schedule of Diagnostic Tests with an effective date of 17 April 2023, meaning claims submitted […]
CCSD code 0049B: Sodium level blood test billing guide
CCSD code 0049B identifies the sodium level blood test, a diagnostic pathology code filed under Chapter 16, Clinical Pathology, of the CCSD Schedule of Diagnostic Tests. Practitioners typically order it to investigate dehydration, fluid overload, confusion, or fatigue, or to monitor patients taking diuretics — the exact clinical reasoning UK private insurers expect to see […]
CCSD code 0046B: Sm (Smith) IgG antibody test billing guide
CCSD code 0046B identifies the Sm (Smith) immunoglobulin G (IgG) antibody assay, a diagnostic pathology code in Chapter 34.3, the Immunology section of the CCSD Schedule of Diagnostic Tests. Practitioners typically order it after a positive antinuclear antibody (ANA) screen, alongside symptoms suggestive of lupus or a related connective tissue disease. That clinical reason is […]